A. Schultze-Mosgau

A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists

Efstratios M. Κolibianakis, A. Schultze-Mosgau, Andreas Schröer et al. · Human Reproduction · 2005 · 324 citations · Full text

Veterinary Medicine, Endocrinology, Gynecology +15

Three years of routine vitrification of human zygotes: is it still fair to advocate slow-rate freezing?

S. Al‐Hasani, Batuhan Özmen, Nikoleta Koutlaki et al. · Reproductive BioMedicine Online · 2007 · 137 citations · Full text

Veterinary Medicine, Biology, Cryopreservation Of Embryos +15

Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study

Georg Griesinger, S. von Otte, Andreas Schröer et al. · Human Reproduction · 2007 · 129 citations · Full text

Medicine, Endocrinology, Gynecology +17

Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol

Georg Griesinger, A. Schultze-Mosgau, Konstantinos Dafopoulos et al. · Human Reproduction · 2005 · 104 citations

Medicine, Endocrinology, Gynecology +13

Expression and Responsiveness of P2Y₂Receptors in Human Endometrial Cancer Cell Lines

Ann C. Katzur, Taka‐aki Koshimizu, Melanija Tomić et al. · The Journal of Clinical Endocrinology & Metabolism · 1999 · 48 citations · Full text

Life Sciences, Cancer Biology, Pharmacology +17